Sources | Names Used |
---|---|
CTRPv2 | JQ-1:MK-0752 (1:1 mol/mol) |
PharmacoGx | JQ-1:MK-0752 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NT5DC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LILRB4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | NR4A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CD40 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RP11-795F19.5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MTHFS | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | WDR63 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RP11-176H8.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |